scholarly journals Evaluation of Intraperitoneal Instillation of Levobupivacaine versus Ultrasound Guided Rectus Sheath Block for Post-Operative Pain Relief Following Laparoscopic Cholecystectomy

2021 ◽  
Vol 84 (1) ◽  
pp. 2516-2521
Author(s):  
Ahmed A. Metwally ◽  
Nagwa M. Doha ◽  
Amany A. Sultan ◽  
Hend A. Okasha
Keyword(s):  
Laparoscopic Cholecystectomy ◽  
Pain Relief ◽  
Rectus Sheath ◽  
Ultrasound Guided ◽  
Post Operative Pain ◽  
Rectus Sheath Block ◽  
Intraperitoneal Instillation

scholarly journals ULTRASOUND-GUIDED RECTUS SHEATH BLOCK ALONG WITH RIGHT SIDE SUBCOSTAL TRANSVERSE ABDOMINIS PLANE BLOCK VERSUS PORTSITE INFILTRATION WITH LOCAL ANESTHETICS IN LAPAROSCOPIC CHOLECYSTECTOMY FOR POST-OPERATIVE PAIN RELIEF: A COMPARATIVE STUDY

2020 ◽  
pp. 99-104
Author(s):  
RAJIV D MISHRA ◽  
MADHUSMITA PARIDA ◽  
SWASTIKA SWARO ◽  
SOUMYA SAMAL
Keyword(s):  
Laparoscopic Cholecystectomy ◽  
Pain Relief ◽  
Local Anesthetics ◽  
Rectus Sheath ◽  
Ultrasound Guided ◽  
Post Operative Pain ◽  
Rectus Sheath Block ◽  
Transverse Abdominis ◽  
Group A ◽  
Group B

Objectives: The objective of the study was to compare the efficacy between ultrasound guided rectus sheath block and the right side subcostal transverse abdominis plane with portsite infiltration with local anesthetics in laparoscopic cholecystectomy for post operative pain relief. Methods: Sixty patients posted for laparoscopic cholecystectomy were divided into two groups of 30 each. Group A received total dose of 80 mg (16 ml) of 0.5% ropivacaine 4 ml in each port and Group B received bilateral rectus sheath block with right-sided subcostal TAP block postoperatively, 80 mg (40 ml) of 0.2% ropivacaine was divided into two parts 20 ml in right-sided subcostal TAP and 20 ml in rectus sheath block, 10 ml in each side. Results: The first request of analgesia was significantly longer in combined block group than in the port site infiltration group (p=0.000). The numeric rating scale was reduced in patients given with abdominal field blocks when compared to patients obtaining port site infiltration. Mean NRS score was peak in pain score at the 6th h postoperatively in Group A and remained higher till 24 h in comparison Group B and was statistically significant. The overall tramadol consumption in Group A was approximately twice (215±51 mg) as compared to Group B (105±28 mg). Three cases of PONV were seen in Group A that is not statistically significant. The patient satisfaction score after 24 h was much higher with Group B in comparison to Group A (P 0.000). Conclusion: It is concluded that ultrasound-guided right-sided subcostal TAP and rectus sheath block produce effective post-operative analgesia for the incisional pain in laparoscopic cholecystectomy surgeries and act as a supplementary method in multimodal analgesia.

scholarly journals Efficacy of ultrasound-guided rectus sheath block, butorphanol for single-incision laparoscopic cholecystectomy: A prospective, randomized, clinical trial

2019 ◽  
Author(s):  
Huimin Fu ◽  
Chaochao Zhong ◽  
Yongtao Gao ◽  
Xingguo Xu
Keyword(s):  
Clinical Trial ◽  
Laparoscopic Cholecystectomy ◽  
General Anesthesia ◽  
Visceral Pain ◽  
Single Incision ◽  
Rectus Sheath ◽  
Ultrasound Guided ◽  
Rectus Sheath Block ◽  
Single Incision Laparoscopic Cholecystectomy ◽  
Vas Scores

Abstract Background: Whether rectus sheath block (RSB) combined with butorphanol can relieve incision pain and visceral pain in patients undergoing single-incision laparoscopic cholecystectomy (SILC) remains unknown. The goal of this study was to assess the efficacy of ultrasound-guided bilateral RSB, butorphanol on postoperative analgesia in patients undergoing SILC. Methods: All 116 patients who met the criteria were randomly divided into four groups: (Ⅰ) (n=29) general anesthesia combined with patient controlled intravenous analgesia (PCIA) (sufentanil 100ug); (Ⅱ) (n=29) general anesthesia combined with PCIA (butorphanol 8mg); (Ⅲ) (n=29) ultrasound-guided RSB combined with PCIA (sufentanil 100ug). (Ⅳ) (n=29) RSB combined with PCIA (butorphanol 8mg). Outcomes included visual analog scale (VAS) scores of incisional and visceral pain at rest and cough at 2,6,12 and 24h postoperatively, if a patient’s pain score＞3, then butorphanol 2mg was administered intravenously. the dose of butorphanol and opioids, the pressing numbers of PCIA, the length of hospital stay and the incidence of postoperative adverse events. Results: Both rest and cough pain scores were lower during first 2,6 hours in group Ⅲ than groupⅠ, similarly, group Ⅳwas significantly lower than groupⅡ. GroupⅠneeded more butorphanol as rescue analgesic for pain relief than group Ⅲ, group Ⅳ was better than group Ⅱ. In the above pairwise comparisons, it was clear that group Ⅲ and group Ⅳ had lower VAS scores. VAS scores of visceral pain was lower in groupⅡ at 2, 6 and 12 h after surgery compared with the groupⅠ. In the both groups Ⅲ and Ⅳ, the group Ⅳ was also lower than groupⅢ. Overall, RSB combined with PCIA (butorphanol 8mg) is the best match. Conclusions: Ultrasound-guided RSB combined with butorphanol can provide sufficient pain treatment after SILC. Trial registration: The study was registered prospectively with the Chinese Clinical Trial Registry（reg no.ChiCTR1900020738), obtained ethics committee of Affiliated Hospital of Nantong University approval (approved number: 2018-K067).

Ultrasound-guided rectus sheath block for single-incision laparoscopic cholecystectomy

2015 ◽  
Vol 8 (2) ◽  
pp. 148-152 ◽  
Author(s):  
Hideki Kamei ◽  
Nobuya Ishibashi ◽  
Gouichi Nakayama ◽  
Nobuya Hamada ◽  
Yutaka Ogata ◽  
...  
Keyword(s):  
Laparoscopic Cholecystectomy ◽  
Single Incision ◽  
Rectus Sheath ◽  
Ultrasound Guided ◽  
Rectus Sheath Block ◽  
Single Incision Laparoscopic Cholecystectomy

scholarly journals Efficacy of ultrasound-guided rectus sheath block, butorphanol for single-incision laparoscopic cholecystectomy: A prospective, randomized, clinical trial

2019 ◽  
Author(s):  
Huimin Fu ◽  
Chaochao Zhong ◽  
Yongtao Gao ◽  
Xingguo Xu
Keyword(s):  
Clinical Trial ◽  
Laparoscopic Cholecystectomy ◽  
General Anesthesia ◽  
Visceral Pain ◽  
Single Incision ◽  
Rectus Sheath ◽  
Ultrasound Guided ◽  
Rectus Sheath Block ◽  
Single Incision Laparoscopic Cholecystectomy ◽  
Vas Scores

Abstract Background: Whether rectus sheath block (RSB) combined with butorphanol can relieve incision pain and visceral pain in patients undergoing single-incision laparoscopic cholecystectomy (SILC) remains unknown. The goal of this study was to assess the efficacy of ultrasound-guided bilateral RSB, butorphanol on postoperative analgesia in patients undergoing SILC. Methods: All 116 patients who met the criteria were randomly divided into four groups: (Ⅰ) (n=29) general anesthesia combined with patient controlled intravenous analgesia (PCIA) (sufentanil 100ug); (Ⅱ) (n=29) general anesthesia combined with PCIA (butorphanol 8mg); (Ⅲ) (n=29) ultrasound-guided RSB combined with PCIA (sufentanil 100ug). (Ⅳ) (n=29) RSB combined with PCIA (butorphanol 8mg). Outcomes included visual analog scale (VAS) scores of incisional and visceral pain at rest and cough at 2,6,12 and 24h postoperatively, if a patient’s pain score＞3, then butorphanol 2mg was administered intravenously. the dose of butorphanol and opioids, the pressing numbers of PCIA, the length of hospital stay and the incidence of postoperative adverse events. Results: Both rest and cough pain scores were lower during first 2,6 hours in group Ⅲ than groupⅠ, similarly, group Ⅳwas significantly lower than groupⅡ. GroupⅠneeded more butorphanol as rescue analgesic for pain relief than group Ⅲ, group Ⅳ was better than group Ⅱ. In the above pairwise comparisons, it was clear that group Ⅲ and group Ⅳ had lower VAS scores. VAS scores of visceral pain was lower in groupⅡ at 2, 6 and 12 h after surgery compared with the groupⅠ. In the both groups Ⅲ and Ⅳ, the group Ⅳ was also lower than groupⅢ. Overall, RSB combined with PCIA (butorphanol 8mg) is the best match. Conclusions: Ultrasound-guided RSB combined with butorphanol can provide sufficient pain treatment after SILC. Trial registration: The study was registered prospectively with the Chinese Clinical Trial Registry（reg no.ChiCTR1900020738), obtained ethics committee of Affiliated Hospital of Nantong University approval (approved number: 2018-K067).

Sign in / Sign up

Export Citation Format

Share Document